In an interim management statement, Skyepharma Plc said its financial position has improved after it recently paid off £95.6 million pounds of bond debt thereby cutting its debt service payments by £8.1 million in 2014 and £13.3 million in 2015. Its remaining debt is only £4.8 million.
